Literature DB >> 29031850

Nucleic acid loading and fluorescent labeling of isolated extracellular vesicles requires adequate purification.

Stephan Stremersch1, Toon Brans1, Kevin Braeckmans1, Stefaan De Smedt2, Koen Raemdonck3.   

Abstract

Extracellular vesicles (EVs) are nanosized vesicular structures released by cells to communicate with one another. The growing interest in the (patho)physiological function and potential pharmaceutical application of these vesicles is accompanied by a vast number of new research groups entering this research field and a plethora of different protocols to separate EVs from non-vesicular components. This lack of uniformity often generates conflicting or difficult-to-compare results. Here we provide a comparative analysis of different EV isolation strategies, discussing the purity of the final isolate and highlighting the importance of purity on downstream experimental readouts. First, we show that ultracentrifugation (UC) of B16F10 melanoma cell-derived conditioned medium co-purifies proteins or protein complexes with nuclease activity. Such contaminants should be taken into account when aiming to apply EVs as delivery carriers for exogenous nucleic acids. Second, three commonly used purification strategies (i.e. precipitation, UC and density-gradient centrifugation) were evaluated for their ability to remove non-incorporated fluorescent dye (i.e. the lipophilic PKH67 dye), important when probing EV interactions with cells. For both types of impurities, endogenous and exogenous, density gradient purification outperforms the other evaluated methods. Overall, these results demonstrate that the implementation of stringent purification protocols and adequate controls is of pivotal importance to draw reliable conclusions from downstream experiments performed with EV isolates.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Density gradient; Extracellular vesicles; Fluorescence; Ultracentrifugation; siRNA

Mesh:

Substances:

Year:  2017        PMID: 29031850     DOI: 10.1016/j.ijpharm.2017.10.022

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

Review 1.  Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV.

Authors:  Ava Behrouzi; Hoora Mazaheri; Sarvenaz Falsafi; Zahra Hoseini Tavassol; Arfa Moshiri; Seyed Davar Siadat
Journal:  J Diabetes Metab Disord       Date:  2020-05-01

2.  Optimized Cholesterol-siRNA Chemistry Improves Productive Loading onto Extracellular Vesicles.

Authors:  Reka Agnes Haraszti; Rachael Miller; Marie-Cecile Didiot; Annabelle Biscans; Julia F Alterman; Matthew R Hassler; Loic Roux; Dimas Echeverria; Ellen Sapp; Marian DiFiglia; Neil Aronin; Anastasia Khvorova
Journal:  Mol Ther       Date:  2018-06-21       Impact factor: 11.454

Review 3.  Extracellular vesicle-derived miRNA as a novel regulatory system for bi-directional communication in gut-brain-microbiota axis.

Authors:  Liang Zhao; Yingze Ye; Lijuan Gu; Zhihong Jian; Creed M Stary; Xiaoxing Xiong
Journal:  J Transl Med       Date:  2021-05-11       Impact factor: 5.531

Review 4.  Perspectives in Manipulating EVs for Therapeutic Applications: Focus on Cancer Treatment.

Authors:  Katarzyna Nazimek; Krzysztof Bryniarski
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

Review 5.  Exosome and Macrophage Crosstalk in Sleep-Disordered Breathing-Induced Metabolic Dysfunction.

Authors:  Abdelnaby Khalyfa; Leila Kheirandish-Gozal; David Gozal
Journal:  Int J Mol Sci       Date:  2018-10-29       Impact factor: 5.923

6.  Efficient Route to Label Mesenchymal Stromal Cell-Derived Extracellular Vesicles.

Authors:  Diego Alberti; Cristina Grange; Stefano Porta; Silvio Aime; Lorenzo Tei; Simonetta Geninatti Crich
Journal:  ACS Omega       Date:  2018-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.